BRPI0908365A2 - Paramixovírus antitumor efetivo - Google Patents

Paramixovírus antitumor efetivo

Info

Publication number
BRPI0908365A2
BRPI0908365A2 BRPI0908365-0A BRPI0908365A BRPI0908365A2 BR PI0908365 A2 BRPI0908365 A2 BR PI0908365A2 BR PI0908365 A BRPI0908365 A BR PI0908365A BR PI0908365 A2 BRPI0908365 A2 BR PI0908365A2
Authority
BR
Brazil
Prior art keywords
paramyxovirus
effective antitumor
antitumor
effective
antitumor paramyxovirus
Prior art date
Application number
BRPI0908365-0A
Other languages
English (en)
Inventor
Rudolf Beier
Florian Pühler
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of BRPI0908365A2 publication Critical patent/BRPI0908365A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0908365-0A 2008-02-14 2009-02-12 Paramixovírus antitumor efetivo BRPI0908365A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08075121 2008-02-14
US2965008P 2008-02-19 2008-02-19
PCT/EP2009/051659 WO2009101149A2 (en) 2008-02-14 2009-02-12 Anti-tumour effective paramyxovirus

Publications (1)

Publication Number Publication Date
BRPI0908365A2 true BRPI0908365A2 (pt) 2015-08-11

Family

ID=40955326

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908365-0A BRPI0908365A2 (pt) 2008-02-14 2009-02-12 Paramixovírus antitumor efetivo

Country Status (17)

Country Link
US (1) US20090208495A1 (pt)
EP (1) EP2252307A2 (pt)
JP (1) JP2011512344A (pt)
KR (1) KR20100122482A (pt)
CN (1) CN101945660A (pt)
AU (1) AU2009214066A1 (pt)
BR (1) BRPI0908365A2 (pt)
CA (1) CA2715136A1 (pt)
CO (1) CO6290694A2 (pt)
CR (1) CR11631A (pt)
DO (1) DOP2010000251A (pt)
EA (1) EA201001266A1 (pt)
EC (1) ECSP10010401A (pt)
IL (1) IL206860A0 (pt)
MX (1) MX2010008942A (pt)
WO (1) WO2009101149A2 (pt)
ZA (1) ZA201006561B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105331633A (zh) 2009-08-21 2016-02-17 梅里亚有限公司 重组禽副粘病毒疫苗及其制备和使用方法
GB0915515D0 (en) * 2009-09-04 2009-10-07 Ucl Business Plc Treatment of vasculoproliferative conditions
JP5603486B2 (ja) * 2010-06-10 2014-10-08 インターベット インターナショナル ベー． フェー． 抗腫瘍組成物
MY173638A (en) * 2012-01-24 2020-02-12 Univ Georgia Parainfluenza virus 5 based vaccines
KR102310692B1 (ko) * 2013-09-03 2021-10-12 메디뮨 리미티드 약독화된 뉴캐슬병 바이러스를 특징으로 하는 조성물 및 신생물을 치료하기 위한 사용 방법
JOP20190256A1 (ar) 2017-05-12 2019-10-28 Icahn School Med Mount Sinai فيروسات داء نيوكاسل واستخداماتها
JP2021530501A (ja) * 2018-07-13 2021-11-11 アイカーン スクール オブ メディシン アット マウント サイナイ 癌の治療のためのａｐｍｖ及びその使用
WO2020037215A1 (en) 2018-08-17 2020-02-20 Icahn School Of Medicine At Mount Sinai Recombinant newcastle disease viruses and uses thereof for the prevention of rsv disease or human metapneumovirus disease
CN115089591B (zh) * 2022-05-21 2024-04-12 复旦大学 布立尼布在制备抑制肠道病毒71型嗜神经性病毒药物中的应用
CN116970650B (zh) * 2023-09-22 2023-12-08 深圳华大生命科学研究院 一种包膜蛋白组合、含其的靶向病毒载体及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ550861A (en) * 1999-04-15 2009-03-31 Wellstat Biologics Corp Treatment of neoplasms with viruses
AU7607900A (en) * 1999-09-22 2001-04-24 Mayo Foundation For Medical Education And Research Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
EP2292246A1 (en) * 2004-11-12 2011-03-09 Bayer Schering Pharma Aktiengesellschaft Recombinant Newcastle Disease Virus

Also Published As

Publication number Publication date
AU2009214066A1 (en) 2009-08-20
EP2252307A2 (en) 2010-11-24
JP2011512344A (ja) 2011-04-21
EA201001266A1 (ru) 2011-04-29
KR20100122482A (ko) 2010-11-22
MX2010008942A (es) 2010-09-07
CA2715136A1 (en) 2009-08-20
CO6290694A2 (es) 2011-06-20
ZA201006561B (en) 2012-02-29
DOP2010000251A (es) 2010-08-31
CN101945660A (zh) 2011-01-12
ECSP10010401A (es) 2010-09-30
US20090208495A1 (en) 2009-08-20
WO2009101149A3 (en) 2009-11-05
IL206860A0 (en) 2010-12-30
WO2009101149A2 (en) 2009-08-20
CR11631A (es) 2010-10-05

Similar Documents

Publication Publication Date Title
BRPI0906764A2 (pt) Processos
BRPI0921327A2 (pt) Combinação de herbicida-protetor
DK2370462T3 (da) Glucagon-analoger
DK2342317T3 (da) Hængende-dråbe-plade
DE602009000234D1 (de) msignals
BRPI0907376A2 (pt) Fotobiorretador
DK3444343T3 (da) Polypeptider
BRPI0914649A2 (pt) Piprazolo-quinazolinas
DE602008003972D1 (de) Sitzrücklehnungsmechanismus
DE602008003521D1 (de) Sitzrücklehnungsmechanismus
DK2342454T3 (da) Vindkraftanlæg
DK2336132T3 (da) Morpholinpurinderivat
DK2335031T3 (da) In-line-måler
DK2379557T3 (da) Aminopyrazol-forbindelse
DK2271613T3 (da) Hydroxymethylcyklohexylaminer
DE602008003970D1 (de) Strahlstromkalibriersystem
EP2257170A4 (en) TETRAHYDROFUROPYRIDONE
EP2248964A4 (en) DRILLING / TERMINAL DEVICE
BRPI0907522A2 (pt) biarlamidas
EP2259958A4 (en) LINKAGE
DE112009000183A5 (de) Sicherheitsvorreiber
IL206860A0 (en) Anti-tumour effective paramyxovirus
BRPI0909634A2 (pt) 2-aminoquinolinas
DE602009000862D1 (de) Gehwagenbremse
BRPI0922728A2 (pt) combinação de herbicida-antídoto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.